Although elevated blood pressure (BP) levels are a common complication of acute stroke, whether of ischaemic or haemorrhagic type, a long-standing debate exists regarding the management of post-stroke hypertension. In the absence of solid, randomised data from controlled trials, the current observational evidence allows different approaches, since theoretical arguments exist for both lowering BP in the setting of acute stroke (reduce the risk of stroke recurrence, of subsequent oedema formation, of rebleeding and haematoma expansion in patients with cerebral bleeding) as well as leaving raised BP levels untreated (avoid reduction in cerebral perfusion pressure and blood flow to viable ischaemic tissue in the absence of normal autoregulation). The present review will summarize the evidence for and against the therapeutic manipulation of BP in acute stroke provided by the currently available observational studies and randomised trials, consider the ongoing clinical trials in this area and address the present recommendations regarding this conflicting issue.

Keywords:
Acute stroke, Blood pressure, Hypertension
1.
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Prospective studies collaboration: age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–1913.
2.
Chalmers J, Todd A, Chapman N, et al: International Society of Hypertension Writing Group. International Society of Hypertension Writing Group. International Society of Hypertension (ISH): statement on blood pressure lowering and stroke prevention. J Hypertens 2003;21:651–663.
3.
Donnan GA, Davis SM, Thrift A: The role of blood pressure lowering before and after stroke. Curr Opin Neurol 2003;16:81–86.
4.
Rashid P, Leonardi-Bee J, Bath P: Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003;34:2741–2748.
5.
CAST (Chinese Acute Stroke Trial) Collaborative Group: (CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 1997;349:1641–1649.
6.
International Stroke Trial Collaborative Group: The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19,435 patients with acute ischaemic stroke. Lancet 1997;349:1569–1581.
7.
Britton M, Carlsson A, de Faire U: Blood pressure course in patients with acute stroke and matched controls. Stroke 1986;17:861–864.
8.
Myers MG, Norris JW, Hachniski VC, Sole MJ: Plasma norepinephrine in stroke. Stroke 1981;12:200–204.
9.
Olson T, Marklund N, Gustafson Y, Nasman B: Abnormalities at different levels of the hypothalamic-pituitary adrenocortical axis early after stroke. Stroke 1992;23:1573–1576.
10.
Carlberg B, Asplund K, Hagg E: High blood pressure in acute stroke – is it white coat hypertension? J Intern Med 1990;228:291–292.
11.
Ito A, Omae T, Katsuki S: Acute changes in blood pressure following vascular diseases in the brain stem. Stroke 1973;4:80–84.
12.
Harper G, Castleden CM, Potter JF: Factors affecting changes in blood pressure after acute stroke. Stroke 1994;25:1726–1729.
13.
Vemmos KN, Tsivgoulis G, Spengos K, et al: Blood pressure course in acute ischaemic stroke varies in relation to stroke subtype. Blood Press Monit 2004;9:107–114.
14.
Vemmos K,Spengos K, Tsivgoulis G, et al: Factors influencing acute blood pressure values in stroke subtypes. J Hum Hypertens 2004;18:253–259.
15.
Yatsu FM, Zivin J: Hypertension in acute ischemic strokes: not to treat. Arch Neurol 1985;42:999–1000.
16.
Spencer JD: Hypertension in acute ischemic stroke: to treat. Arch Neurol 1985;42:1000–1002.
17.
Robinson TG, Potter JF: Blood pressure in acute stroke. Age Ageing 2004;33:6–12.
18.
Bath P, Chalmers J, Powers W, et al: International Society of Hypertension Writing Group. International Society of Hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens 2003;21:665–672.
19.
Willmot M, Leonardi-Bee J, Bath PM: High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004;43:18–24.
20.
Blood Pressure in Acute Stroke Collaboration (BASC): Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database Syst Rev 2001:CD000039.
21.
Broderick J, Brott T, Barsan W, et al: Blood pressure during the first minutes of focal cerebral ischemia. Ann Emerg Med 1993;22:1438–1443.
22.
Carlberg B, Asplund K, Hagg E: Course of blood pressure in different subsets of patients after acute stroke. Cerebrovasc Dis 1991;1:281–287.
23.
Powers WJ: Acute hypertension after acute stroke: the scientific basis for treatment decisions. Neurology 1993;43:461–467.
24.
Fischberg GM, Lozano E, Rajamani K, Ameriso S, Fisher MJ: Stroke precipitated by moderate blood pressure reduction. J Emerg Med 2000;19:339–346.
25.
Oliveira-Filho J, Silva SC, Trabuco CC, Pedreira BB, Sousa EU, Bacellar A: Detrimental effect of blood pressure reduction in the first 24 h of acute stroke onset. Neurology 2003;61:1047–1051.
26.
Castillo J, Leira R, Garcia MM, Serena J, Blanco M, Davalos A: Blood pressure decrease during the acute phase of ischemic stroke is associated with brain injury and poor stroke outcome. Stroke 2004;35:520–526.
27.
Wahlgren NG, MacMahon DG, de Keyser J, Indredavik B, Ryman T, INWEST Study Group: Intravenous Nimodipine West European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis 1994;4:204–210.
28.
Ahmed N, Nasman P, Wahlgren NG: Effect of intravenous nimodipine on blood pressure and outcome after acute stroke. Stroke 2000;31:1250–1255.
29.
Mattle HP, Kappeler L, Arnold M, et al: Blood pressure and vessel recanalization in the first hours after ischemic stroke. Stroke 2005;36:264–268.
30.
Morfis L, Schwartz RS, Poulos R, Howes LG: Blood pressure changes in acute cerebral infarction and hemorrhage. Stroke 1997;28:1401–1405.
31.
Zazulia AR, Diringer MN, Videen TO, et al: Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab. 2001;21:804–810.
32.
Videen TO, Dunford-Shore JE, Diringer MN, Powers WJ: Correction for partial volume effects in regional blood flow measurements adjacent to hematomas in humans with intracerebral hemorrhage: implementation and validation. J Comput Assist Tomogr 1999;23:248–256.
33.
Kuwata N, Kuroda K, Funayama M, Sato N, Kubo N, Ogawa A: Dysautoregulation in patients with hypertensive intracerebral hemorrhage: a SPECT study. Neurosurg Rev 1995;18:237–245.
34.
Vemmos K, Tsivgoulis G, Spengos K, et al: Association between 24-h blood pressure monitoring variables and oedema formation in patients with hyperacute stroke. J Hypertens 2003;21:2167–2173.
35.
Leonardi-Bee J, Bath PM, Phillips SJ, Sandercock PA, IST Collaborative Group: Blood pressure and clinical outcomes in the International Stroke Trial. Stroke 2002;33:1315–1320.
36.
Sacco RL, Foulkes MA, Mohr JP, Wolf PA, Hier DB, Price TR: Determinants of early recurrence of cerebral infarction. The Stroke Data Bank. Stroke 1989;20:983–989.
37.
Hier DB, Foulkes MA, Swiontoniowski M, et al: Stroke recurrence within 2 years after ischaemic infarction. Stroke 1991;22:155–161.
38.
Tsivgoulis G, Spengos K, Zakopoulos N, Manios E, Vassilopoulos D, Vemmos K: Twenty-four-hour pulse pressure predicts long-term recurrence in acute stroke patients. J Neurol Neurosurg Psychiatry 2005;76:1360–1365.
39.
Kazui S, Minematsu K, Yamamoto H, Sawada T, Yamaguchi T: Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997;28:2370–2375.
40.
Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A: Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004;35:1364–1367.
41.
Arakawa S, Saku Y, Ibayashi S, Nagao T, Fujishima M: Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke 1998;29:1806–1809.
42.
Broderick JP, Adams HP Jr, Barsan W, et al: Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 1999;30:905–915.
43.
Adams HP Jr, Adams RJ, Brott T, et al: Stroke Council of the American Stroke Association. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056–1083.
44.
Vemmos KN, Tsivgoulis G, Spengos K, et al: U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med 2004;255:257–265.
45.
Okumura K, Ohya Y, Maehara A, Wakugami K, Iseki K, Takishita S: Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 2005;23:1217–1223.
46.
Bath PMW, Pathansali R, Iddenden R, Bath FJ: The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis 2001;11:265–272.
47.
Eames PJ, Robinson TG, Panerai RB, Potter JF: Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period. Cerebrovasc Dis 2005;19:253–259.
48.
PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033–1041.
49.
Bosch J, Yusuf S, Pogue J, et al: HOPE Investigators. Heart outcomes prevention evaluation: use of ramipril in preventing stroke: double blind randomised trial. Br Med J 2002;324:699–702.
50.
Dyker AG, Grosset DG, Lees K: Perindopril reduces blood pressure but not cerebral blood flow in patients with recent cerebral ischemic stroke. Stroke 1997;28:580–583.
51.
Schrader J, Luders S, Kulschewski A, et al: Acute Candesartan Cilexetil Therapy in Stroke Survivors Study Group (2003). The ACCESS Study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke 2003;34:1699–1703.
52.
Adams H, Adams R, Del Zoppo G, Goldstein LB: Stroke Council of the American Heart Association; American Stroke Association (2005). Guidelines for the early management of patients with ischemic stroke: 2005 guidelines update a scientific statement from the Stroke Council of the American Heart Association/American Stroke Association. Stroke 2005;36:916–923.
53.
Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JR: Low dose beta blockade in acute stroke (‘BEST’ trial): an evaluation. Br Med J 1998;296:737–741.
54.
Brott T, Lu M, Kothari R, et al: Hypertension and its treatment in the NINDS rt-PA Stroke Trial. Stroke 1998;29:1504–1509.
55.
Horn J, Limburg M: Calcium antagonists for ischemic stroke: a systematic review. Stroke 2001;32:570–576.
56.
Patel RV, Kertland HR, Jahns BE, Zarowitz BJ, Mlynarek ME, Fagan SC: Labetalol: response and safety in critically ill hemorrhagic stroke patients. Ann Pharmacother 1993;27:180–181.
57.
Nishiyama T, Yokoyama T, Matsukawa T, Hanaoka K: Continuous nicardipine infusion to control blood pressure after evacuation of acute cerebral hemorrhage. Can J Anaesth 2000;47:1196–1201.
58.
Powers WJ, Zazulia AR, Videen TO, et al: Autoregulation of cerebral blood flow surrounding acute (6 to 22 hs) intracerebral hemorrhage. Neurology 2001;57:18–24.
59.
Qureshi AI, Mohammad YM, Yahia AM, et al: A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intens Care Med 2005;20:34–42.
60.
Potter J, Robinson T, Ford G, et al: The CHHIPS Trial Group. CHHIPS (Controlling Hypertension and Hypotension Immediately Post-Stroke) Pilot Trial: rationale and design. J Hypertens 2005;23:649–655.
61.
Bath PM, Willmot MR, Weaver C, Leonardi-Bee J: Efficacy of nitric oxid in stroke (ENOS) trial – a prospective randomised controlled trial in acute stroke. Cerebrovasc Dis 2002;13(suppl 3):79.
62.
COSSACS Trial Group: COSSACS (Continue or Stop Post-Stroke Antihypertensives Collaborative Study): rationale and design. J Hypertens 2005;23:455–458.
63.
Rordorf G, Cramer SC, Efird JT, Schwamm LH, Buonanno FS, Koroshetz WJ: Pharmacological elevation of blood pressure in acute stroke: clinical effects and safety. Stroke 1997;28:2133–2138.
64.
Rordorf G, Koroshetz WJ, Ezzeddine MA, Segal AZ, Buonanno FS: A pilot study of drug induced hypertension for treatment of acute stroke. Neurology 2001;56:1210–1213.
65.
Schwarz S, Georgiadis D, Aschoff A, Schwab S: Effects of induced hypertension on intracranial pressure and flow velocities of the middle cerebral arteries in patients with large hemispheric stroke. Stroke 2002;33:998–1004.
66.
Hillis AE, Ulatowski JA, Barker BP, et al: A pilot randomized trial of induced blood pressure elevation: effects on function and focal perfusion in acute and subacute stroke. Cerebrovasc Dis 2003;16:236–246.
67.
Robinson T, Waddington A, Ward-Close S, Taub N, Potter J: The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke. Cerebrovasc Dis 1997;7:264–272.
68.
Dawson SL, Manktelow BN, Robinson TG, Panerai RB, Potter JF: Which parameters of beat-to-beat blood pressure and variability best predict early outcome after acute ischemic stroke? Stroke 2000;31:463–468.
69.
Robinson TG, Dawson SL, Eames PJ, Panerai RB, Potter JF: Cardiac baroreceptor sensitivity predicts long-term outcome after acute ischemic stroke. Stroke 2003;34:705–712.
70.
Kernan WN, Viscoli CM, Brass LM, et al: Phenylpropanolamine and the risk of hemorrhagic stroke. N Engl J Med 2000;43:1826–1832.
71.
Saxena R, Wijnhoud AD, Carton H, et al: Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke 1999;20:993–996.
72.
Hacke W, Kaste M, Bogousslavsky J, et al: European Stroke Initiative Executive Committee and the EUSI Writing Committee. European Stroke Initiative Recommendations for Stroke Management – Update 2003. Cerebrovasc Dis 2003;16:311–337.
73.
Cottrell JE, Patel K, Turndorf H, Ransohoff J: Intracranial pressure changes induced by sodium nitroprusside in patients with intracranial mass lesions. J Neurosurg 1978;48:329–331.
74.
Davalos A, Cendra E, Teruel J, Martinez M, Genis D: Deteriorating ischemic stroke: risk factors and prognosis. Neurology 1990;40:1865–1869.
75.
Carlberg B, Asplund K, Hagg E: The prognostic value of admission blood pressure in patients with acute stroke. Stroke 1993;24:1372–1375.
76.
Toni D, Fiorelli M, Gentile M, et al: Progressing neurological deficit secondary to acute ischemic stroke: a study on predictability, pathogenesis, and prognosis. Arch Neurol 1995;52:670–675.
77.
Finocchi C, Gandolfo C, Gasparetto B, Del Sette M, Croce R, Loeb C: Value of early variables as predictors of short-term outcome in patients with acute focal cerebral ischemia. Ital J Neurol Sci 1996;17:341–346.
78.
Chamorro A, Vila N, Ascaso C, Elices E, Schonewille W, Blanc R: Blood pressure and functional recovery in acute ischemic stroke. Stroke 1998;29:1850–1853.
79.
Ahmed N, Wahlgren G: High initial blood pressure after acute stroke is associated with poor functional outcome. J Intern Med 2001;249:467–473.
80.
Bhalla A, Wolfe CD, Rudd AG: The effect of 24 h blood pressure levels on early neurological recovery after stroke. J Intern Med 2001;250:121–130.
81.
Boreas AM, Lodder J, Kessels F, de Leeuw PW, Troost J: Prognostic value of blood pressure in acute stroke. J Hum Hypertens 2002;16:111–116.
82.
Aslanyan S, Fazekas F, Weir CJ, Horner S, Lees KR: GAIN International Steering Committee and Investigators. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN International Trial. Stroke 2003;34:2420–2425.
83.
Semplicini A, Maresca A, Boscolo G, et al: Hypertension in acute ischemic stroke: a compensatory mechanism or an additional damaging factor? Arch Intern Med 2003;163:211–216.
84.
Vlcek M, Schillinger M, Lang W, Lalouschek W, Bur A, Hirschl MM: Association between course of blood pressure within the first 24 h and functional recovery after acute ischemic stroke. Ann Emerg Med. 2003;42:619–626.
85.
Rodriguez-Garcia JL, Botia E, de La Sierra A, Villanueva MA, Gonzalez-Spinola J: Significance of elevated blood pressure and its management on the short-term outcome of patients with acute ischemic stroke. Am J Hypertens 2005;18:379–384.
86.
Stead LG, Gilmore RM, Decker WW, Weaver AL, Brown RD Jr: Initial emergency department blood pressure as predictor of survival after acute ischemic stroke. Neurology 2005;65:1179–1183.
87.
Dunne JW, Chakera T, Kermode S: Cerebellar haemorrhage – diagnosis and treatment: a study of 75 consecutive cases. Q J Med 1987;64:739–754.
88.
Broderick JP, Brott TG, Duldner JE, Tomsick T, Huster G: Volume of intracerebral hemorrhage: a powerful and easy-to-use predictor of 30-day mortality. Stroke 1993;24:987–993.
89.
Dandapani BK, Suzuki S, Kelley RE, Reyes-Iglesias Y, Duncan RC: Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995;26:21–24.
90.
Qureshi AI, Safdar K, Weil J, et al: Predictors of early deterioration and mortality in black Americans with spontaneous intracerebral hemorrhage. Stroke 1995;26:1764–1767.
91.
Fogelholm R, Avikainen S, Murros K: Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 1997;28:1396–1400.
92.
Terayama Y, Tanahashi N, Fukuuchi Y, Gotoh F: Prognostic value of admission blood pressure in patients with intracerebral hemorrhage. Keio Cooperative Stroke Study. Stroke 1997;28:1185–1188.
93.
Leira R, Davalos A, Silva Y, et al: Stroke Project, Cerebrovascular Diseases Group of the Spanish Neurological Society. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 2004;63:461–467.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.